#MERCKCO News
7 ‘A-Rated’ Aggressive Biotech Stocks to Bet On in 2024
investorplace.com If you have patience, biotech stocks can be big winners The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with…
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer at AACR 2024
benzinga.com HELSINKI, Finland, April 10, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies presented…
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
benzinga.com Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts Favorable clinical safety and tolerability…